Owens & Minor Analysts Boost Their Forecasts After Q2 Results

Benzinga

Aug 13

Owens & Minor, Inc. (NYSE:OMI) reported worse-than-expected second-quarter earnings on Monday.

Owens & Minor posted adjusted earnings of 26 cents per share, missing market estimates of 27 cents per share.

Owens & Minor said it sees FY2025 adjusted EPS of $1.02-$1.07 and sales of $2.760 billion-$2.820 billion.

“We are in the final stages of our robust process for the divestiture of the Products & Healthcare Services segment, and, as a result, have classified this segment as discontinued operations. We are looking forward to concluding the sale of the business and working with a buyer who has the vision and greater flexibility to better support our customers and long-term growth,” said Ed Pesicka, Owens & Minor’s Chief Executive Officer.

Owens & Minor shares jumped 18% to close at $5.47 on Tuesday.

These analysts made changes to their price targets on Owens & Minor following earnings announcement.

B of A Securities analyst Allen Lutz maintained Owens & Minor with an Underperform rating and lowered the price target from $7.5 to $4.75.
Citigroup analyst Daniel Grosslight maintained Owens & Minor with a Buy and lowered the price target from $11 to $7.
Baird analyst Eric Coldwell maintained Owens & Minor with an Outperform rating and lowered the price target from $10 to $7.

Considering buying OMI stock? Here’s what analysts think:

Read This Next:

Cramer Expects This FinTech To Reach $100, Upset With Eli Lilly: ‘Come Back And Talk To Me’

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2559213836"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2559213836\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2559213836?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-13 04:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2559213836","market":"hk","top_or_hot":-1,"title":"Owens & Minor Analysts Boost Their Forecasts After Q2 Results","media":"Benzinga","content":"<html><body><p><strong>Owens &amp; Minor, Inc</strong>. (NYSE:OMI) reported worse-than-expected second-quarter earnings on Monday.</p>\n<p>Owens &amp; Minor posted adjusted earnings of 26 cents per share, missing market estimates of 27 cents per share.</p>\n<p>Owens &amp; Minor said it sees FY2025 adjusted EPS of $1.02-$1.07 and sales of $2.760 billion-$2.820 billion.</p>\n<p>“We are in the final stages of our robust process for the divestiture of the Products &amp; Healthcare Services segment, and, as a result, have classified this segment as discontinued operations. We are looking forward to concluding the sale of the business and working with a buyer who has the vision and greater flexibility to better support our customers and long-term growth,” said Ed Pesicka, Owens &amp; Minor’s Chief Executive Officer.</p>\n<p>Owens &amp; Minor shares jumped 18% to close at $5.47 on Tuesday.</p>\n<p>These analysts made changes to their price targets on Owens &amp; Minor following earnings announcement.</p>\n<ul>\n<li>B of A Securities analyst Allen Lutz maintained Owens &amp; Minor with an Underperform rating and lowered the price target from $7.5 to $4.75.</li>\n<li>Citigroup analyst Daniel Grosslight maintained Owens &amp; Minor with a Buy and lowered the price target from $11 to $7.</li>\n<li>Baird analyst Eric Coldwell maintained Owens &amp; Minor with an Outperform rating and lowered the price target from $10 to $7.</li>\n</ul>\n<p><strong>Considering buying OMI stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"582\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/12161113/image-213-1024x582.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/12161113/image-213-1024x582.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/12161113/image-213-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/12161113/image-213-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/12161113/image-213.png 1108w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Cramer Expects This FinTech To Reach $100, Upset With Eli Lilly: ‘Come Back And Talk To Me’</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Owens & Minor Analysts Boost Their Forecasts After Q2 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOwens & Minor Analysts Boost Their Forecasts After Q2 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2025-08-13 04:12</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>Owens &amp; Minor, Inc</strong>. (NYSE:OMI) reported worse-than-expected second-quarter earnings on Monday.</p>\n<p>Owens &amp; Minor posted adjusted earnings of 26 cents per share, missing market estimates of 27 cents per share.</p>\n<p>Owens &amp; Minor said it sees FY2025 adjusted EPS of $1.02-$1.07 and sales of $2.760 billion-$2.820 billion.</p>\n<p>“We are in the final stages of our robust process for the divestiture of the Products &amp; Healthcare Services segment, and, as a result, have classified this segment as discontinued operations. We are looking forward to concluding the sale of the business and working with a buyer who has the vision and greater flexibility to better support our customers and long-term growth,” said Ed Pesicka, Owens &amp; Minor’s Chief Executive Officer.</p>\n<p>Owens &amp; Minor shares jumped 18% to close at $5.47 on Tuesday.</p>\n<p>These analysts made changes to their price targets on Owens &amp; Minor following earnings announcement.</p>\n<ul>\n<li>B of A Securities analyst Allen Lutz maintained Owens &amp; Minor with an Underperform rating and lowered the price target from $7.5 to $4.75.</li>\n<li>Citigroup analyst Daniel Grosslight maintained Owens &amp; Minor with a Buy and lowered the price target from $11 to $7.</li>\n<li>Baird analyst Eric Coldwell maintained Owens &amp; Minor with an Outperform rating and lowered the price target from $10 to $7.</li>\n</ul>\n<p><strong>Considering buying OMI stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"582\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/12161113/image-213-1024x582.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/12161113/image-213-1024x582.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/12161113/image-213-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/12161113/image-213-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/12161113/image-213.png 1108w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Cramer Expects This FinTech To Reach $100, Upset With Eli Lilly: ‘Come Back And Talk To Me’</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OMI","symbol_name":"欧麦斯-麦能医疗","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/47074282/owens-minor-analysts-boost-their-forecasts-after-q2-results","article_id":"2559213836","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2559213836","pubTimestamp":1755029564,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OMI":"欧麦斯-麦能医疗","BK4175":"保健护理产品经销商"},"translate_title":"Owens&Minor分析师在第二季度业绩公布后上调预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMI":1},"content_text":"Owens & Minor, Inc. (NYSE:OMI) reported worse-than-expected second-quarter earnings on Monday.\nOwens & Minor posted adjusted earnings of 26 cents per share, missing market estimates of 27 cents per share.\nOwens & Minor said it sees FY2025 adjusted EPS of $1.02-$1.07 and sales of $2.760 billion-$2.820 billion.\n“We are in the final stages of our robust process for the divestiture of the Products & Healthcare Services segment, and, as a result, have classified this segment as discontinued operations. We are looking forward to concluding the sale of the business and working with a buyer who has the vision and greater flexibility to better support our customers and long-term growth,” said Ed Pesicka, Owens & Minor’s Chief Executive Officer.\nOwens & Minor shares jumped 18% to close at $5.47 on Tuesday.\nThese analysts made changes to their price targets on Owens & Minor following earnings announcement.\n\nB of A Securities analyst Allen Lutz maintained Owens & Minor with an Underperform rating and lowered the price target from $7.5 to $4.75.\nCitigroup analyst Daniel Grosslight maintained Owens & Minor with a Buy and lowered the price target from $11 to $7.\nBaird analyst Eric Coldwell maintained Owens & Minor with an Outperform rating and lowered the price target from $10 to $7.\n\nConsidering buying OMI stock? Here’s what analysts think:\n\nRead This Next: \n\nCramer Expects This FinTech To Reach $100, Upset With Eli Lilly: ‘Come Back And Talk To Me’\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}